Handeln Abbvie - ABBV CFD

AbbVie Inc. (ABBV) is a research-based pharmaceutical company specialising in the discovery and development of biopharmaceuticals, and small molecule drugs. With a team of 28,000 scientists and researchers across the globe, the company introduces new approaches to treating chronic conditions and life-threatening health issues. AbbVie produces medicines aimed at treating autoimmune diseases; oncology; virology, including hepatitis C and HIV; neurological; and metabolic disorders. The company focuses on developing and delivering innovative solutions for treating the most dangerous and challenging diseases known worldwide. Browse the AbbVie share price (ABBV) chart in real-time and seize an investment opportunity with a world-leading pharmaceutical company at Capital.com.